Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701779 · ClinicalTrials.gov registry record · Phase 4
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
A Phase 4 study, sponsored by Siami, Paul F., M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT00701779 is a Phase 4 study that has completed, run by Siami, Paul F., M.D.. The registered enrollment target is 63 participants.
The verdict
NCT00701779, a Phase 4 study, has completed, sponsored by Siami, Paul F., M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
This study will investigate the efficacy and safety of treatment with Dutasteride (0.5mg), administered once daily for one year in combination with Tamsulosin (0.4mg), administered once daily for 3 months, followed by counseling on flexible dosing of Tamsulosin on an as needed basis, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic benign prostatic hyperplasia (BPH). At each scheduled visit (3, 6, and 9 months), the subject will be counseled on withdrawal of Tamsulosin. After randomization, study visits are every 13 weeks for up to 52 Weeks. (Including Screening, (up to 7 clinic visits)
Interventions
- DRUG Tamsulosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00701779
The ClinicalTrials.gov registry entry for NCT00701779 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Siami, Paul F., M.D., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tamsulosin is the first listed.
NCT00701779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00701779 about?
NCT00701779 is a clinical study titled "Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia". This study will investigate the efficacy and safety of treatment with Dutasteride (0.5mg), administered once daily for one year in combination with Tamsulosin (0.4mg), administered once daily for 3 months, followed by counseling on flexible dosing of Tamsulosin on an as needed basis, on the improvem...
What is the current status of trial NCT00701779?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2005-09. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00701779?
The interventions under investigation include: Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT00701779?
This trial is sponsored by Siami, Paul F., M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.